Literature DB >> 18649116

Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.

Josephina A Vossen1, Manon Buijs, Labiq Syed, Fatima Kutiyanwala, Mustafa Kutiyanwala, Jean-Francois H Geschwind, Mustafa Vali.   

Abstract

AIM: The aim of our study was to compare the influence of partial hepatectomy, intra-arterial treatment with 3-BrPA and TACE on regional and distant metastases. In order to achieve our objective, we tested the feasibility of both resection, intra-arterial therapy with 3-BrPA and TACE of VX2 liver cancer in New Zealand White rabbits.
METHODS: VX2 tumors were implanted in the left lateral lobe of the liver of 20 rabbits. Tumors were allowed to grow for 14 days. Rabbits were divided in four groups. Group 1 (n=2) was sacrificed 14 days post implantation. Group 2, 3 and 4 (n=6) underwent left lateral hepatectomy, a 1 h intra-arterial infusion with 3-BrPA and TACE respectively. Animals in each group were further subdivided into three groups of two animals each corresponding to the time-point of sacrifice after the procedure (7, 14 and 21 days respectively). After sacrifice, organs were harvested, fixed and analyzed.
RESULTS: Pathologic examination showed lung metastases in all 20 rabbits. Abdominal cavity dissemination was seen in five rabbits in Group 2, two rabbits in Group 3 and all rabbits in Group 4. Kidney metastases were seen in two rabbits treated with TACE.
CONCLUSION: The VX2 rabbit model of liver cancer is a suitable model to compare the influence of partial hepatectomy, intra-arterial treatment with 3-BrPA and TACE on tumor recurrence in the form of regional and distant metastases. Our results indicate that intra-arterial delivery of 3-BrPA may result in a favorable metastatic profile when compared to both liver resection and TACE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18649116     DOI: 10.1007/s10585-008-9195-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  26 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Epidemiology and carcinogenesis of hepatocellular carcinoma.

Authors:  Trishe Y-M Leong; Anthony S-Y Leong
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

3.  Critical factors in the biology of human cancer metastasis.

Authors:  I J Fidler
Journal:  Am Surg       Date:  1995-12       Impact factor: 0.688

4.  Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.

Authors:  Y H Ko; P L Pedersen; J F Geschwind
Journal:  Cancer Lett       Date:  2001-11-08       Impact factor: 8.679

Review 5.  Treatment of hepatocellular carcinoma.

Authors:  Alejandro Forner; Amelia J Hessheimer; M Isabel Real; Jordi Bruix
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-24       Impact factor: 6.312

6.  Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods.

Authors:  J H Chen; Y C Lin; Y S Huang; T J Chen; W Y Lin; K W Han
Journal:  Lab Anim       Date:  2004-01       Impact factor: 2.471

Review 7.  Modeling metastasis in vivo.

Authors:  Chand Khanna; Kent Hunter
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

8.  Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.

Authors:  Mustafa Vali; Josephina A Vossen; Manon Buijs; James M Engles; Eleni Liapi; Veronica Prieto Ventura; Afsheen Khwaja; Obele Acha-Ngwodo; Shanmugasundaram Ganapathy-Kanniappan; Ganapathy Shanmugasundaram; Labiq Syed; Richard L Wahl; Jean-Francois H Geschwind
Journal:  J Pharmacol Exp Ther       Date:  2008-06-30       Impact factor: 4.030

Review 9.  Hepatocellular carcinoma: an update.

Authors:  Hubert E Blum; Hans Christian Spangenberg
Journal:  Arch Iran Med       Date:  2007-07       Impact factor: 1.354

10.  Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the Vx2 carcinoma of the power to immunize hosts against the papilloma virus.

Authors:  P ROUS; J G KIDD; W E SMITH
Journal:  J Exp Med       Date:  1952-08       Impact factor: 14.307

View more
  6 in total

1.  Development of a VX2 pancreatic cancer model in rabbits: a pilot study.

Authors:  Aaron C Eifler; Robert J Lewandowski; Sumeet Virmani; Johnathan C Chung; Dingxin Wang; Richard L Tang; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Robert K Ryu; Riad Salem; Andrew C Larson; Eric Cheon; Matthew Strouch; David J Bentrem; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2009-06-28       Impact factor: 3.464

2.  Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: a pilot study.

Authors:  Keiko Yoshida; Tomihiko Hirokawa; Fuminori Moriyasu; Longzhong Liu; Guang-Jian Liu; Masahiko Yamada; Yasuharu Imai
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

3.  Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?

Authors:  Lynn Jeanette Savic; Julius Chapiro; Gregor Duwe; Jean-François Geschwind
Journal:  Hepat Oncol       Date:  2016-01-01

Review 4.  The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.

Authors:  J Azevedo-Silva; O Queirós; F Baltazar; S Ułaszewski; A Goffeau; Y H Ko; P L Pedersen; A Preto; M Casal
Journal:  J Bioenerg Biomembr       Date:  2016-07-25       Impact factor: 2.945

5.  Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.

Authors:  Sarah B White; Jeane Chen; Andrew C Gordon; Kathleen R Harris; Jodi R Nicolai; Derek L West; Andrew C Larson
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

6.  Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study.

Authors:  Rajagopal N Aravalli; Erik N K Cressman
Journal:  J Clin Med       Date:  2015-12-04       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.